M. Agirbasli Et Al. , "Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy," JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1, pp.59-63, 2011
Agirbasli, M. Et Al. 2011. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1 , 59-63.
Agirbasli, M., Eren, M., EREN, F., Murphy, S. B., Serdar, Z. A., SEÇKİN GENÇOSMANOĞLU, D., ... Zara, T.(2011). Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy. JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1, 59-63.
Agirbasli, Mehmet Et Al. "Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy," JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1, 59-63, 2011
Agirbasli, Mehmet Et Al. "Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1, pp.59-63, 2011
Agirbasli, M. Et Al. (2011) . "Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy." JOURNAL OF THROMBOSIS AND THROMBOLYSIS , vol.32, no.1, pp.59-63.
@article{article, author={Mehmet Agirbasli Et Al. }, title={Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy}, journal={JOURNAL OF THROMBOSIS AND THROMBOLYSIS}, year=2011, pages={59-63} }